Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1614, 2007-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept of greater value than adalimumab or infliximab for RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Access to resources
Recommend
Adalimumab more cost effective than infliximab in early RA
Inpharma, Vol. 1, Iss. 1499, 2005-01 ,pp. :
Adalimumab more cost effective than infliximab in early RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. :
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 25 case reports
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :